Showing results (161-170 of 327) with videos related to
Sort By:
Pageof 33
Human Brain Mapping|March 23, 2012
The structural correlates of functional deficits in early huntington's diseaseChristine Delmaire, Eve M Dumas, Michael A Sharman, et al.European Journal of Human Genetics : EJHG|May 13, 2010
A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42)Nina A Schlipf, Christian Beetz, Rebecca Schüle, et al.Brain : a Journal of Neurology|May 23, 2018
Testing a longitudinal compensation model in premanifest Huntington's diseaseSarah Gregory, Jeffrey D Long, Stefan Klöppel, et al.Science (New York, N.Y.)|July 18, 2020
Huntington's disease alters human neurodevelopmentMonia Barnat, Mariacristina Capizzi, Esther Aparicio, et al.Human Molecular Genetics|September 22, 2017
Mutations in TGM6 induce the unfolded protein response in SCA35Debasmita Tripathy, Beatrice Vignoli, Nandini Ramesh, et al.American Journal of Human Genetics|April 9, 2008
Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndromeSylvain Hanein, Elodie Martin, Amir Boukhris, et al.Journal of Huntington'S Disease|July 27, 2014
Corpus callosal atrophy in premanifest and early Huntington's diseaseHelen E Crawford, Nicola Z Hobbs, Ruth Keogh, et al.Archives of Neurology|April 12, 2012
Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegiaSophie Tezenas du Montcel, Perrine Charles, Cyril Goizet, et al.American Journal of Human Genetics|April 16, 2024
CAG repeat mosaicism is gene specific in spinocerebellar ataxiasRadhia Kacher, François-Xavier Lejeune, Isabelle David, et al.The Lancet. Neurology|December 6, 2011
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational dataSarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, et al.Pageof 33